Therapeutic efficacy and drug safety comparison of one-week Vonoprazan triple therapy with two-weeks Esomeprazole triple therapy in Helicobacter pylori infection: Findings from a single-centre randomized clinical trial in population of Pakistan

Therapeutic efficacy and drug safety comparison of one-week Vonoprazan triple therapy with two-weeks Esomeprazole triple therapy in Helicobacter pylori infection: Findings from a single-centre randomized clinical trial in population of Pakistan

Objective: To compare the therapeutic efficacy and drug safety of Vonoprazan and Esomeprazole triple therapies in Helicobacter pylori infection. Method: The randomised clinical trial was conducted from December 2022 to January 2023 at the Department of Pharmacology, Army Medical College, National...

Full description

Bibliographic Details
Main Authors: Farzana Waqar, Mudassar Noor, Ehtesham Haider, Kulsoom Farhat, Shabana Ali, Syedah Fauzia Fatime Gilani
Format: Article
Language:English
Published: Pakistan Medical Association 2024-02-01
Series:Journal of the Pakistan Medical Association
Subjects:
Helicobacter pylori
Eradication
Vonoprazan
Esomeprazole
Levofloxacin
Online Access:https://ojs.jpma.org.pk/index.php/public_html/article/view/9545

Internet

https://ojs.jpma.org.pk/index.php/public_html/article/view/9545

Similar Items